Monthly informal lunchtime session hosted by Nikolai Ahrens.

Alex Brunicki - Co-Founder and Partner at Backed

Yasmin Siraj - Investment Manager at Backed

Backed has helped 110+ entrepreneurs successfully scale 60+ companies across Europe and they have seen a lot of founders make mistakes along the way in their early journeys.

Maximilien Levesque - CEO at AQEMIA

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Alex Gould - Founder and CEO of Long Story Short

A seasoned communications and design specialist, Alex is an expert at simplifying and transforming technical subject matter into compelling campaigns that excite and persuade audiences.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Mark Kotter - Founder and CEO of bit.bio

Mark Kotter is a stem cell biologist and neurosurgeon at the University of Cambridge.

Matt Abrahams - Lecturer in Organizational Behavior at Stanford University’s Graduate School of Business

Matt is a leading expert in communication with decades of experience as an educator, author, podcast host, and coach.

Anna Sumeray - CEO at Virometix

Anna Sumeray has over 25 years of experience in the life sciences sector with a combination of strategic consultancy, hands-on P&L leadership and deal transaction experience in big pharmaceutical and small biotechnology companies, globally, across Europe and within individual countries.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jack Scannell - CEO at Etheros

He is an Associate of the Department of Science, Technology, and Innovation Studies at Edinburgh University. He led Discovery Biology at e-Therapeutics PLC. He has experience in drug and biotech investment at UBS and at Sanford Bernstein where he ran the European Healthcare teams. He has a Ph.D. in neuroscience from Oxford University and a degree in medical sciences from Cambridge University.

Danuta Jeziorska - CEO & Academic Founder at Nucleome Therapeutics

Danuta has been the CEO of Nucleome since its inception has deep expertise in gene regulation, transcription, epigenetics, 3D genome analysis and bioinformatics. In acknowledgement of her achievements at Nucleome, Danuta was recently recognised as an outstanding leader in the biotech sector by leading scientific journal Nature Biotechnology.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Tariq Ahmed - EVP People, Achilles Therapeutics

Tariq Ahmed serves as Executive Vice President, People at Achilles Therapeutics helping navigate their growth from a small private bio-tech to a NASDAQ listed company.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Jim Van heusden - Chair Rewind Tx, Breye Tx, Ankrin Tx

Jim has more than 30 years’ experience in research and development and financial, business and operating management in the biotech industry. He is the managing director of bioskills bv.

Tom Weaver - Founder & CEO at Petmedix

Tom has more than 20 years of experience in technology development, specializing in genomic-based research and drug discovery, as well as commercial expertise in building and managing multifunctional teams and developing business in the EU, USA and China.

Gretchen Schweitzer - Managing Director at Trophic Communications

Gretchen founded Trophic Communications in 2017 bringing with her 25+ years as a strategic communicator and investor relations specialist in the global biopharmaceutical industry.

Monthly informal lunchtime session hosted by Nikolai Ahrens.

Bennett Golder - Managing Director at FGS Global

Bennett is a Managing Director at strategic communications agency FGS Global and a specialist in digital corporate communication strategy.

Carolin Barth - Partner & Director at Boston Consulting Group and former CEO MiroBio

Carolin joined Miro Bio as CEO in September 2021, having previously served at Novartis as Global Head of Commercial and Pipeline Strategy, Cell and Gene. During a 17-year stint at Novartis, Carolin Barth shepherded the development and launches of several antibody therapies that included two blockbuster drugs, Cosentyx® (secukinumab) and Xolair® (omalizumab).

Monthly informal lunchtime session hosted by Nikolai Ahrens.

John Cassidy - Partner at Kindred Capital

John is an entrepreneur with dual expertise in cancer biology and financial economics. He has over 10 years’ experience in drug development; spanning academia (University of Cambridge), industry (MedImmune) and start-ups.

Philipp Baaske - Co-Founder & CEO of NanoTemper

Philipp Baaske is a hard-core scientist (Biophysicist), the scientific co-founder and CEO of the Munich-based biotech company NanoTemper, and also an Angel investor.

Giuseppe Marzio - Founder of Chiaro

Giuseppe is a seasoned scientist-turned-communication pro with over twenty years of experience in the biopharmaceutical industry. He recently published a book Winners Have a Story which is an easy read and very informative. It became an Amazon bestseller.

Maura Thomas - International Award-Winning Speaker and Trainer on Productivity and Work-Life Balance

Maura is the most widely-cited authority on attention management and she is a TEDx Speaker, business owner, six-time author, and was named a Top Leadership Speaker for 2018 in Inc. Magazine.

Oliver Harrison - Founder/CEO of Koa Health

Oliver is trained as a medical doctor and spent 20 years practicing as a psychiatrist, McKinsey health tech consultant, Director of Public Health and entrepreneur.

Andrew Harrow - Partner at Goodwin and - Sophie McGrath -Partner at Goodwin

The Goodwin life science team has unparalleled experience partnering with emerging life sciences companies, from formation through financing to an exit event.

Daniela Marino - CEO at CUTISS AG

Daniela is the Co-Founder and CEO of CUTISS. CUTISS won the Top 100 Swiss Start-up Award and has raised more than CHF 65 million from private investors, family offices and public bodies.

Max Klement - Principal in the Novo Ventures team of Novo Holdings

Max currently serves on the board of F2G, and has served on the boards of Complement Tx, Link Immunotherapeutics, Dualyx, and VarmX.